Galderma Group N Enterprise Value to EBITDA (EV/EBITDA) on August 15, 2025: 42.45

Galderma Group N Enterprise Value to EBITDA (EV/EBITDA) is 42.45 on August 15, 2025, a 32.03% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Galderma Group N 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 44.40 on August 15, 2025, which is 4.59% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Galderma Group N 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 23.50 on August 15, 2025, which is -44.65% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Galderma Group N average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 34.84.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization